Navigation Links
Dr. Ben Goldacre to Keynote PhUSE Annual Conference

Brussels, Belgium (PRWEB) February 07, 2013

PhUSE, a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical information, is proud to announce that Dr. Ben Goldacre will present the Keynote at the 2013 PhUSE Annual Conference. The 2013 conference focus is ‘Patient Centricity’ in the pharmaceutical world.

As a physician and academic writer Doctor Ben Goldacre will speak to the PhUSE community about how patient centric thinking will help to bring efficacious new drugs to patients. In his latest book "Bad Pharma" Doctor Ben Goldacre gives a critical insight into the 600 billion dollar global pharmaceutical industry. In his keynote Doctor Goldacre will share his views on the process of new drug approval. He will tell the PhUSE community how flaws in the planning, conduct and publication of studies conducted by the pharmaceutical industry can harm the life of patients.

In his keynote for PhUSE, Doctor Goldacre will address the interests of all involved parties: the patients, pharmaceutical drug companies, regulatory bodies and payers.

Discussion groups for conference attendees will expand upon the themes of the keynote, giving attendees the opportunity to learn and share knowledge about creating better outcomes for patients through their work with clinical trial data.

Registration for the conference is open. Sponsorship opportunities are available.

About Doctor Goldacre:
Ben Goldacre is an award-winning writer, broadcaster, and medical doctor who specializes in unpicking scientific claims made by scaremongering journalists, government reports, pharmaceutical corporations, PR companies and quacks. He was trained in Medicine at Oxford and London, and currently works as an academic in epidemiology. Ben wrote the weekly Bad Science column in the Guardian from 2003-2011. Bad Science the book (4th Estate) has sold over half a million copies worldwide, reached #1 in the paperback non-fiction charts, and is being published in 25 languages. In his new book, Bad Pharma (4th Estate, September 2012) Ben puts the $600bn global pharmaceutical industry under the microscope. What he reveals is a fascinating, terrifying mess.

About PhUSE
PhUSE, Share – Contribute – Advance, provides the industry with the premier platform for creating and sharing ideas, tools and standards around data, statistical and reporting technologies; PhUSE is a non-profit, volunteer-supported, community of professionals who are passionate about advancement of clinical information. Since its inception, PhUSE has expanded from its roots as a conference for European Statistical Programmers, to a global platform for the discussion of topics encompassing the work of Data Managers, Biostatisticians, Statistical Programmers and eClinical IT professionals.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
2. Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobels Frank Sherman Delivers Keynote Address
3. National Defense Industrial Association's (NDIA) 2012 Biosurveillance Conference To Feature Keynote Speaker Laurie Garrett, Pulitzer Prize Winner and Bestselling Author
4. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
5. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
6. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
7. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
8. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
9. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
10. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
11. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015 Spherix Incorporated (Nasdaq: ... to the fostering and monetization of intellectual property, ... prospective initiatives designed to create shareholder value. ... of Spherix. "Based on published reports, the total ... $50 billion and Spherix will seek to secure ...
(Date:11/30/2015)... 2015 Human Longevity, Inc. (HLI), the genomics-based, ... Cypher Genomics, Inc., a leading genome informatics company offering ... solutions. The San Diego -based company ... CEO and Co-founder, Ashley Van Zeeland , Ph.D., who ... details of the deal were not disclosed. ...
(Date:11/30/2015)... ENGLEWOOD, Colo. , Nov. 30, 2015  Aytu ... focused on urological and related conditions, will present at ... live at, an interactive real-time virtual conference, to ... Main Event Investor Conference, to be held December 2 ... Los Angeles and streamed live via ...
(Date:11/30/2015)... , Nov. 30, 2015  Northwest Biotherapeutics (NASDAQ: ... developing DCVax® personalized immune therapies for solid tumor cancers, ... an additional independent director, and the Company welcomes ... allegations in a recent anonymous internet report on NW ... initiatives. Linda Powers stated, "We agree ...
Breaking Biology Technology:
(Date:10/27/2015)... -- Munich, Germany , October ... automatically maps data from mobile eye tracking videos created ... that they can be quantitatively analyzed with SMI,s analysis ... , October 28-29, 2015. SMI,s Automated Semantic Gaze ... tracking videos created with SMI,s Eye Tracking Glasses ...
(Date:10/26/2015)... India , October 26, 2015 ... --> adds ... 2015 to 2021 as well as ... 2015-2019 research reports to its collection ... . --> ...
(Date:10/26/2015)... Calif. , Oct. 26, 2015  Delta ID ... biometric authentication to mobile and PC devices, announced its ... smartphone, the arrows NX F-02H launched by NTT DOCOMO, ... NX F-02H is the second smartphone to include iris ... technology in ARROWS NX F-04G in May 2015, world,s ...
Breaking Biology News(10 mins):